Instil Bio Is Maintained at Buy by HC Wainwright & Co.
H.C. Wainwright Maintains Instil Bio(TIL.US) With Buy Rating, Cuts Target Price to $110
Instil Bio Analyst Ratings
JMP Securities Maintains Instil Bio(TIL.US) With Hold Rating
Instil Bio (TIL) Gets a Hold From JMP Securities
JMP Securities Initiates Instil Bio(TIL.US) With Hold Rating
Instil Bio Analyst Ratings
Baird Maintains Instil Bio(TIL.US) With Buy Rating, Maintains Target Price $180
Baird Maintains Instil Bio(TIL.US) With Buy Rating, Maintains Target Price $180
Baird Maintains Instil Bio(TIL.US) With Buy Rating, Maintains Target Price $180
H.C. Wainwright Maintains Instil Bio(TIL.US) With Buy Rating, Maintains Target Price $120
Instil Bio Is Maintained at Buy by HC Wainwright & Co.
Baird Maintains Instil Bio(TIL.US) With Buy Rating, Maintains Target Price $180
H.C. Wainwright Maintains Instil Bio(TIL.US) With Buy Rating, Raises Target Price to $120
Baird Maintains Instil Bio(TIL.US) With Buy Rating, Raises Target Price to $180
Instil Bio Is Maintained at Buy by HC Wainwright & Co.
H.C. Wainwright Maintains Instil Bio(TIL.US) With Buy Rating, Raises Target Price to $40
Instil Bio Analyst Ratings
Instil Bio's SYN-2510 Shows Promise: A Strong Buy Rating With Increased Price Target
Baird Maintains Instil Bio(TIL.US) With Buy Rating, Maintains Target Price $32
No Data
No Data